×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Pharmacy Market

ID: MRFR/MED/50768-HCR
200 Pages
Garvit Vyas
October 2025

South America Pharmacy Market Research Report By Product Type (Prescription Drugs, Over-The-Counter Drugs, Vaccines, Homeopathic Medicine), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Specialty Pharmacy), By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Neurology, Infectious Diseases), By Formulation (Tablets, Injectables, Topicals, Liquids) and By Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Pharmacy Market Infographic
Purchase Options

South America Pharmacy Market Summary

As per MRFR analysis, the South America pharmacy market Size was estimated at 111.11 USD Billion in 2024. The South America pharmacy market is projected to grow from 116.19 USD Billion in 2025 to 181.56 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.57% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South America pharmacy market is experiencing a dynamic shift towards digitalization and consumer-focused services.

  • Brazil remains the largest market in South America, driven by a robust pharmaceutical sector.
  • Mexico is emerging as the fastest-growing region, reflecting increasing investments in healthcare infrastructure.
  • Digital transformation is reshaping pharmacy operations, enhancing accessibility and efficiency for consumers.
  • Rising demand for pharmaceuticals and increasing health awareness are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 111.11 (USD Billion)
2035 Market Size 181.56 (USD Billion)

Major Players

CVS Health (US), Walgreens Boots Alliance (US), UnitedHealth Group (US), Cigna (US), Roche (CH), Novartis (CH), Sanofi (FR), AstraZeneca (GB), Teva Pharmaceutical Industries (IL)

South America Pharmacy Market Trends

The pharmacy market in South America is currently experiencing a dynamic transformation, driven by various factors including technological advancements, regulatory changes, and evolving consumer preferences. The region's healthcare landscape is increasingly influenced by digital health solutions, which are reshaping how pharmacies operate and interact with patients. Telepharmacy and e-commerce platforms are gaining traction, allowing consumers to access medications and health services more conveniently. This shift not only enhances patient engagement but also streamlines pharmacy operations, potentially leading to improved health outcomes. Moreover, the regulatory environment in South America is adapting to accommodate these changes, with governments focusing on enhancing access to medications and ensuring the safety of pharmaceutical products. This regulatory evolution appears to foster innovation within the pharmacy market, encouraging the adoption of new technologies and practices. As a result, pharmacies are likely to expand their roles beyond traditional dispensing functions, potentially becoming integral players in the broader healthcare ecosystem. The interplay of these factors suggests a promising outlook for the pharmacy market in South America, characterized by growth and increased consumer accessibility to healthcare services.

Digital Transformation

The pharmacy market is witnessing a significant shift towards digital solutions. E-commerce platforms and telepharmacy services are becoming more prevalent, allowing consumers to order medications online and consult with pharmacists remotely. This trend enhances convenience and accessibility, particularly in remote areas.

Regulatory Adaptation

Regulatory frameworks in South America are evolving to support the changing landscape of the pharmacy market. Governments are implementing policies aimed at improving access to medications and ensuring the safety of pharmaceutical products, which may encourage innovation and growth within the sector.

Consumer-Centric Services

Pharmacies are increasingly focusing on consumer needs, offering personalized services and health consultations. This trend reflects a broader shift towards patient-centered care, where pharmacies play a crucial role in managing health and wellness, potentially leading to better health outcomes.

South America Pharmacy Market Drivers

Increasing Health Awareness

There is a growing trend of health awareness among consumers in South America, which is positively influencing the pharmacy market. As individuals become more informed about health issues and preventive care, they are more likely to seek out medications and health products. This shift is reflected in the rising sales of over-the-counter (OTC) medications and health supplements. Recent statistics indicate that the OTC segment is expected to grow by 12% annually, driven by increased consumer spending on health and wellness. Additionally, educational campaigns by health organizations are further promoting the importance of medication adherence and preventive care, which could lead to a more proactive approach to health management. Consequently, this heightened awareness is likely to bolster the pharmacy market in the region.

Rising Demand for Pharmaceuticals

The pharmacy market in South America is experiencing a notable increase in demand for pharmaceuticals, driven by a growing population and rising healthcare needs. As the population ages, the prevalence of chronic diseases such as diabetes and hypertension is on the rise, leading to an increased consumption of prescription medications. According to recent data, the pharmaceutical sector in South America is projected to grow at a CAGR of approximately 8% over the next five years. This growth is indicative of a broader trend where consumers are seeking more effective treatments, thereby propelling the pharmacy market forward. Additionally, the expansion of health insurance coverage in various countries is likely to enhance access to medications, further stimulating demand within the pharmacy market.

Government Initiatives and Support

Government initiatives aimed at improving healthcare access are playing a crucial role in shaping the pharmacy market in South America. Various countries are implementing policies to enhance the availability of essential medications and reduce costs for consumers. For instance, some governments are subsidizing the prices of critical drugs, making them more affordable for the population. Additionally, regulatory frameworks are being established to streamline the approval process for new medications, which could lead to a more diverse range of products available in the market. These initiatives are expected to foster a more competitive environment within the pharmacy market, potentially leading to a projected growth rate of 7% in the coming years. Such government support is vital for ensuring that the pharmacy market continues to thrive in South America.

Expansion of E-commerce in Pharmacy

The rise of e-commerce is reshaping the pharmacy market in South America, providing consumers with greater access to medications and health products. Online pharmacies are becoming increasingly popular, offering convenience and competitive pricing. This trend is particularly appealing to younger consumers who prefer the ease of online shopping. Data suggests that the online pharmacy segment is expected to grow by 15% over the next few years, driven by the increasing penetration of the internet and mobile devices. Moreover, the COVID-19 pandemic has accelerated the shift towards online purchasing, as consumers seek safer alternatives for obtaining medications. This expansion of e-commerce is likely to create new opportunities for pharmacies to reach a broader customer base, thereby enhancing the overall growth of the pharmacy market.

Technological Advancements in Pharmacy

Technological innovations are significantly impacting the pharmacy market in South America. The integration of advanced technologies such as telepharmacy and electronic health records is transforming how pharmacies operate. These advancements facilitate better patient management and enhance the efficiency of pharmaceutical services. For instance, telepharmacy allows patients in remote areas to access medications and consultations without the need for physical visits. Furthermore, the adoption of automated dispensing systems is improving accuracy and reducing wait times for patients. As a result, pharmacies are likely to see an increase in customer satisfaction and loyalty, which could lead to a projected growth of 10% in the sector over the next few years. This trend underscores the importance of embracing technology in the pharmacy market.

Market Segment Insights

By Product Type: Prescription Drugs (Largest) vs. Over-The-Counter Drugs (Fastest-Growing)

In the South America pharmacy market, the distribution of market share among the various product types reveals that Prescription Drugs hold the largest share, significantly leading against other segments. Over-The-Counter Drugs follow closely, showing a steady performance but with emerging trends that suggest an upward trajectory in consumer preference for non-prescription solutions. Vaccines and Homeopathic Medicine occupy niche markets but are gaining traction in specific demographics, indicating potential for future growth. The growth trends in this segment are largely driven by an increasing prevalence of chronic diseases, which bolster the demand for Prescription Drugs. Additionally, the rising awareness of preventive healthcare is contributing to the rapid growth of Over-The-Counter Drugs. Market dynamics are further influenced by changing regulations, digital health innovations, and a shifting consumer landscape that increasingly favors accessible healthcare solutions.

Prescription Drugs: Dominant vs. Over-The-Counter Drugs: Emerging

Prescription Drugs dominate the market due to their essential role in treating chronic and complex health conditions, being deeply integrated into patient care pathways. Their established presence is supported by strong relationships with healthcare providers and significant investment in R&D. Conversely, Over-The-Counter Drugs, while currently emerging, reflect a shift towards self-medication among consumers, driven by convenience and the increasing trend of telehealth. This segment is characterized by a diverse range of products catering to minor ailments and preventive health, making it adaptable to changing consumer needs. The rapid growth of e-commerce is also fostering wider accessibility and awareness of Over-The-Counter options.

By Distribution Channel: Retail Pharmacy (Largest) vs. Online Pharmacy (Fastest-Growing)

In the South America pharmacy market, Retail Pharmacy holds the largest share, reflecting the traditional reliance on physical outlets for medication access. Retail pharmacies often provide a wide range of products and personalized services, playing a crucial role in community health. Conversely, Online Pharmacy is emerging rapidly, catering to the increasing consumer preference for convenience and accessibility. This shift is driven by the digitalization of healthcare services and a growing trust in e-commerce platforms. The growth trends in this segment are significantly influenced by changing consumer behaviors and advancements in technology. The rise of telehealth and online consultations has bolstered the Online Pharmacy segment, making it the fastest-growing channel. Factors such as increased internet penetration and the demand for contactless service during health crises further accelerate this trend. As customers prioritize ease of access, Online Pharmacy is predicted to capture a larger market share in the coming years.

Retail Pharmacy: Dominant vs. Online Pharmacy: Emerging

Retail Pharmacy serves as the dominant force in the South America pharmacy market, characterized by its established infrastructure and customer trust. These pharmacies provide face-to-face consultations and immediate access to a variety of medications. They benefit from strong relationships with local communities and healthcare providers, ensuring they remain a primary choice for consumers. On the other hand, Online Pharmacy is gaining traction as an emerging competitor, leveraging advancements in digital technology and logistics to streamline the purchasing process. This segment appeals particularly to younger demographics who value convenience and speed. The competitive landscape continues to evolve as both segments adapt to meet changing consumer expectations and market demands.

By Therapeutic Area: Cardiovascular (Largest) vs. Oncology (Fastest-Growing)

In the South America pharmacy market, the therapeutic area segment showcases varied distribution among major categories. Cardiovascular remains the largest segment, holding a significant share. Following closely, Oncology has emerged as the fastest-growing area, gaining traction as advancements in treatment methodologies and drug approvals pave the way for new therapeutic options. This competitive landscape highlights the strong performance of both segments in addressing prevalent health concerns across the region. The growth trends in the therapeutic area segment are driven by a combination of increasing disease prevalence and improved healthcare access. The rising burden of cardiovascular diseases fuels continuous innovation in treatment options, enhancing market dynamics for this segment. Conversely, the rapid growth of Oncology can be attributed to heightened investment in research and development, alongside the introduction of novel therapies. These combined factors are expected to sustain the momentum in the South America pharmacy market.

Cardiovascular (Dominant) vs. Diabetes (Emerging)

The Cardiovascular segment in the South America pharmacy market is characterized by its longstanding dominance, addressing a high volume of cases related to heart diseases. This segment benefits from established treatment protocols and a wide range of medications that cater to diverse patient needs. Healthcare spending and initiatives focused on lifestyle changes further bolster its standing. In contrast, the Diabetes segment is emerging rapidly, fueled by rising obesity rates and increased awareness of diabetes management. With innovative therapies and a growing emphasis on preventive care, it is gaining traction among healthcare providers and patients. The expectations for both segments remain high as they adapt to evolving healthcare landscapes while aiming to improve patient outcomes.

By Formulation: Tablets (Largest) vs. Injectables (Fastest-Growing)

In the South America pharmacy market, the formulation segment showcases a dynamic distribution among its core values: tablets, injectables, topicals, and liquids. Tablets dominate the market due to their widespread usage and cost-effective nature, claiming a significant share. Injectables, while currently holding a smaller portion of the market, are rapidly gaining traction, driven by advancements in technologies and the rising prevalence of chronic diseases that require injectable therapies. The growth trends reveal a promising trajectory for the overall formulation segment, with injectables leading as the fastest-growing category. This surge is fueled by an increasing acceptance of biologic drugs and innovations in delivery methods, enhancing patient compliance. As healthcare infrastructures evolve, the demand for effective dosing methods, including injectables, is expected to escalate, contributing to a vibrant market landscape.

Tablets: Dominant vs. Injectables: Emerging

Tablets hold a dominant position in the formulation segment, largely due to their convenience, stability, and broad acceptance among patients and healthcare providers. They are favored for their ease of administration and cost-effectiveness, making them the first choice for many therapeutic areas. In contrast, injectables have emerged as a rapidly growing segment, particularly in the treatment of chronic conditions such as diabetes and cancer. The shift towards biologics and targeted therapies is propelling the development of injectables, creating a significant market opportunity. While tablets may remain the most accessible formulation, the rise of injectables indicates an evolving landscape with increasing demand for innovative delivery systems.

Get more detailed insights about South America Pharmacy Market

Regional Insights

Brazil : Robust Growth and Demand Trends

Brazil holds a commanding 55.0% market share in South America's pharmacy sector, valued at approximately $15 billion. Key growth drivers include an expanding middle class, increased healthcare spending, and a rising prevalence of chronic diseases. Regulatory support from the National Health Surveillance Agency (ANVISA) has streamlined drug approvals, while government initiatives aim to enhance healthcare access. Infrastructure improvements, particularly in urban areas, bolster distribution networks and pharmacy accessibility.

Mexico : Strong Growth Amid Challenges

With a 25.0% market share, Mexico's pharmacy market is valued at around $7 billion. Growth is driven by rising healthcare awareness, an aging population, and government initiatives to improve healthcare access. Demand for generic medications is increasing, supported by regulatory policies that promote affordability. However, challenges such as regulatory hurdles and market fragmentation persist, impacting growth trajectories.

Argentina : Navigating Economic Challenges

Argentina captures a 20.0% share of the pharmacy market, valued at approximately $5.5 billion. The market is driven by a high demand for pharmaceuticals, particularly generics, due to economic constraints. Government policies aimed at regulating drug prices and enhancing access to essential medications are pivotal. However, inflation and currency fluctuations pose significant challenges to market stability and growth.

Rest of South America : Varied Growth Across Regions

The Rest of South America holds an 11.11% market share, valued at about $3 billion. This sub-region includes diverse markets like Chile, Colombia, and Peru, each with unique growth drivers. Regulatory frameworks vary, impacting market dynamics. Increased healthcare investments and a focus on public health initiatives are common trends. However, infrastructure challenges and varying economic conditions can hinder growth in certain areas.

South America Pharmacy Market Regional Image

Key Players and Competitive Insights

The pharmacy market in South America is characterized by a dynamic competitive landscape, driven by factors such as increasing healthcare demands, a growing aging population, and the rising prevalence of chronic diseases. Key players like CVS Health (US), Walgreens Boots Alliance (US), and Roche (CH) are strategically positioned to leverage these growth drivers. CVS Health (US) focuses on expanding its retail footprint and enhancing its digital health services, while Walgreens Boots Alliance (US) emphasizes partnerships with local healthcare providers to improve service delivery. Roche (CH) is heavily invested in innovation, particularly in personalized medicine, which positions it favorably in a market that increasingly values tailored healthcare solutions. Collectively, these strategies contribute to a competitive environment that is both collaborative and competitive, as companies seek to differentiate themselves through service offerings and technological advancements.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share, yet dominated by a few large entities that exert considerable influence. This fragmentation allows for niche players to thrive, particularly those that can offer specialized services or products tailored to local needs.

In October 2025, Walgreens Boots Alliance (US) announced a strategic partnership with a leading telehealth provider to enhance its service offerings in South America. This move is significant as it aligns with the growing trend of integrating digital health solutions into traditional pharmacy services, thereby improving patient access and engagement. The partnership is expected to bolster Walgreens' competitive edge by providing comprehensive healthcare solutions that cater to the evolving needs of consumers.

In September 2025, Roche (CH) launched a new line of personalized medicine products specifically designed for the South American market. This initiative underscores Roche's commitment to innovation and its strategy to address the unique healthcare challenges faced by the region. By tailoring its offerings, Roche not only enhances its market presence but also positions itself as a leader in the burgeoning field of personalized healthcare, which is likely to gain traction in the coming years.

In August 2025, CVS Health (US) expanded its digital health platform to include AI-driven health management tools aimed at chronic disease patients in South America. This strategic move reflects CVS's focus on leveraging technology to improve patient outcomes and streamline healthcare delivery. The integration of AI into its services may enhance CVS's operational efficiency and customer satisfaction, thereby solidifying its market position.

As of November 2025, current competitive trends in the pharmacy market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing service delivery and expanding market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these areas will be better positioned to thrive in an increasingly complex and competitive landscape.

Key Companies in the South America Pharmacy Market market include

Industry Developments

The South America Pharmacy Market has witnessed significant activity recently, particularly in Brazil, where companies like Drogaria Onofre and Drogaria Araujo have reported an uptick in sales driven by an increase in online pharmacy services. In September 2023, Raia Drogasil announced a partnership with a technology firm to enhance its digital platform, reflecting the ongoing trend toward e-commerce in the pharmacy sector. Furthermore, in July 2023, Grupo UltraPar acquired a stake in Oncofarma, signaling a strategic expansion into cancer care, which is increasingly critical in the region. 

In terms of market valuation, Drogaria Pacheco has seen substantial growth, with estimates indicating a valuation increase of up to 15% in the past year due to the heightened demand for pharmaceutical products post-pandemic. The pharmacy market has also been influenced by regulatory changes, including new pricing policies aimed at increasing access to medications across South America. Over the last two years, the emphasis on health and wellness, accelerated by the COVID-19 pandemic, has led to a persistent growth trend in the pharmacy market, with firms aligning their strategies to focus on both physical and online retail channels.

Future Outlook

South America Pharmacy Market Future Outlook

The pharmacy market in South America is projected to grow at a 4.57% CAGR from 2024 to 2035, driven by increasing healthcare access, technological advancements, and rising chronic disease prevalence.

New opportunities lie in:

  • Expansion of telepharmacy services to enhance patient access and convenience.
  • Development of personalized medication management systems for chronic disease patients.
  • Investment in automated dispensing technologies to improve operational efficiency and reduce costs.

By 2035, the pharmacy market is expected to achieve robust growth, positioning itself as a key player in the healthcare sector.

Market Segmentation

South America Pharmacy Market Formulation Outlook

  • Tablets
  • Injectables
  • Topicals
  • Liquids

South America Pharmacy Market Product Type Outlook

  • Prescription Drugs
  • Over-The-Counter Drugs
  • Vaccines
  • Homeopathic Medicine

South America Pharmacy Market Therapeutic Area Outlook

  • Cardiovascular
  • Oncology
  • Diabetes
  • Neurology
  • Infectious Diseases

South America Pharmacy Market Distribution Channel Outlook

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy

Report Scope

MARKET SIZE 2024111.11(USD Billion)
MARKET SIZE 2025116.19(USD Billion)
MARKET SIZE 2035181.56(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)4.57% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies Profiled["CVS Health (US)", "Walgreens Boots Alliance (US)", "UnitedHealth Group (US)", "Cigna (US)", "Roche (CH)", "Novartis (CH)", "Sanofi (FR)", "AstraZeneca (GB)", "Teva Pharmaceutical Industries (IL)"]
Segments CoveredProduct Type, Distribution Channel, Therapeutic Area, Formulation
Key Market OpportunitiesIntegration of digital health solutions enhances patient engagement in the pharmacy market.
Key Market DynamicsRising demand for personalized medicine drives innovation and competition in South America's pharmacy market.
Countries CoveredBrazil, Mexico, Argentina, Rest of South America

Leave a Comment

FAQs

What is the expected market size of the South America Pharmacy Market in 2024?

The South America Pharmacy Market is expected to be valued at 55.5 USD Billion in 2024.

What will be the market size of the South America Pharmacy Market by 2035?

By 2035, the South America Pharmacy Market is projected to reach a value of 86.0 USD Billion.

What is the expected CAGR for the South America Pharmacy Market from 2025 to 2035?

The expected CAGR for the South America Pharmacy Market from 2025 to 2035 is 4.062%.

Which region holds the largest market share in the South America Pharmacy Market?

Brazil holds the largest market share in the South America Pharmacy Market, valued at 22.5 USD Billion in 2024.

How is the market size for over-the-counter drugs expected to grow by 2035?

The market size for over-the-counter drugs is expected to grow from 15.0 USD Billion in 2024 to 20.0 USD Billion by 2035.

Who are the key players in the South America Pharmacy Market?

Key players include Drogaria Onofre, Drogaria Araujo, and Raia Drogasil among others.

What is the projected market size for vaccines by 2035 in the South America Pharmacy Market?

The projected market size for vaccines by 2035 is expected to be 15.0 USD Billion.

What will be the market value for homeopathic medicine in 2035?

The market value for homeopathic medicine is anticipated to reach 6.0 USD Billion by 2035.

What is the projected growth rate for the pharmacy market in Argentina?

Argentina's pharmacy market is expected to grow from 8.0 USD Billion in 2024 to 12.0 USD Billion by 2035.

What growth opportunities exist in the South America Pharmacy Market?

There are opportunities in emerging trends such as increased demand for homeopathic medicine and online pharmacy services.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions